Fair value (multi-method)
Four independent methods triangulate what TECH is worth. The headline is the Forward-DCF intrinsic value at a normalized growth rate; the margin of safety compares it to the current price.
Estimated fair value (Forward DCF)
$1.96
Method range
$1.96 – $123.69
median $38.18
Valuation methods
Each method’s implied fair value per share and its upside versus the current price. Missing methods (no analyst coverage, negative earnings, etc.) are shown as “—”.
| Method | Fair value | Upside vs price |
|---|---|---|
| Forward DCF | $1.96 | -97.27% |
| Exit multiple | $123.69 | +72.32% |
| Analyst target | $66.44 | -7.44% |
| Graham number | $9.93 | -86.17% |
- Forward DCF$1.96
- Exit multiple$123.69
- Analyst target$66.44
- Graham number$9.93
Stock price
$71.78
FCF / share (TTM)
$0.50
3Y FCF CAGR
-4.1%
Fair value @ hist. growth
$3.77
This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.
Implied FCF growth
38.1%
per year over your projection horizon
Margin of safety -1,804.8% vs hist-growth DCF
Historical 3Y CAGR
-4.1%
Your model implies
38.1%
Analyst consensus is EPS-only — no comparable FCF / share estimate to show on this basis.
Model inputs
Move sliders to test how the reverse DCF reacts. Historical-growth markers show where the company has actually grown over the last cycle.
Undiscounted FCF per share over 10 years at -4% annual growth.
Sensitivity — implied growth vs your assumptions
Each cell shows the per-share growth rate the market would need to justify the current price at that combination of discount rate (rows) and terminal growth (columns). Your selected inputs are highlighted.
| Row axis: discount rate. Column axis: terminal growth.Terminal g →↓ Discount | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 9.1% | 34.4% | 33.6% | 32.7% | 31.8% | 30.8% |
| 10.1% | 36.9% | 36.2% | 35.5% | 34.7% | 33.8% |
| 11.1% | 39.4% | 38.7% | 38.1% | 37.4% | 36.6% |
| 12.1% | 41.7% | 41.1% | 40.5% | 39.9% | 39.2% |
| 13.1% | 43.9% | 43.4% | 42.8% | 42.3% | 41.7% |
Historical multiples
Each bar is the trailing five-year range (low left, high right). Filled portion runs from low to today; the dot marks today; the small tick marks the five-year median. Low, median, and high are listed under each bar.
PEG
1.06
Fair vs growth
Net debt
$282M
Total debt − cash
Beta
1.29
Vs market benchmark
Frequently asked questions
Bio-Techne (TECH) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks1.23% TTM
- Dividend Profile0.45% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History3 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.